avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Sox10 | mm10_v2_chr15_-_79164477_79164496 | -0.01 | 9.6e-01 | Click! |
Sox3 | mm10_v2_chrX_-_60893430_60893440 | 0.00 | 9.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_-_134915512 Show fit | 2.34 |
ENSMUST00000008987.4
|
claudin 13 |
|
chr17_-_79355082 Show fit | 2.06 |
ENSMUST00000068958.7
|
CDC42 effector protein (Rho GTPase binding) 3 |
|
chr10_+_43579161 Show fit | 1.97 |
ENSMUST00000058714.8
|
CD24a antigen |
|
chr4_+_115057683 Show fit | 1.94 |
ENSMUST00000161601.1
|
T cell acute lymphocytic leukemia 1 |
|
chr2_+_155611175 Show fit | 1.78 |
ENSMUST00000092995.5
|
myosin, heavy chain 7B, cardiac muscle, beta |
|
chr7_-_100514800 Show fit | 1.43 |
ENSMUST00000054923.7
|
DnaJ (Hsp40) related, subfamily B, member 13 |
|
chr4_-_34882919 Show fit | 1.42 |
ENSMUST00000098163.2
ENSMUST00000047950.5 |
zinc finger protein 292 |
|
chr4_-_148130678 Show fit | 1.35 |
ENSMUST00000030862.4
|
dorsal inhibitory axon guidance protein |
|
chr2_-_170406501 Show fit | 1.32 |
ENSMUST00000154650.1
|
breast carcinoma amplified sequence 1 |
|
chr4_+_115057410 Show fit | 1.24 |
ENSMUST00000136946.1
|
T cell acute lymphocytic leukemia 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.2 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
0.6 | 2.6 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.2 | 2.4 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.1 | 2.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 2.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 2.2 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.7 | 2.1 | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
0.0 | 2.1 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 1.8 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 1.7 | GO:0001541 | ovarian follicle development(GO:0001541) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.2 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
0.0 | 2.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 2.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 1.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 1.8 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 1.8 | GO:0043034 | costamere(GO:0043034) |
0.0 | 1.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 1.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 1.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 1.5 | GO:0005861 | troponin complex(GO:0005861) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.7 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 3.7 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 2.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 2.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 2.0 | GO:0051117 | ATPase binding(GO:0051117) |
0.4 | 1.9 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 1.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 1.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.2 | 1.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 1.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 1.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 1.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 1.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 1.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 1.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 1.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 3.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 1.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 1.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 1.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |